{
  "decision": "SELL",
  "confidence": 8,
  "volatility": 13.15,
  "sharpe_ratio": -0.94,
  "reasoning": "The stock's weekly performance was disappointing, with a return of -3.1% and a max drawdown of -3.1%. The company's valuation appears to be stretched, with a high trailing P/E ratio of 79.79 and forward P/E ratio of 116.62, indicating that the stock may be overpriced. Additionally, the news sentiment is mixed, but the negative news about Divi's Laboratories may have a more significant impact on the stock market."
}